Aurinia Pharmaceuticals Inc (AUP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 77,114 | 73,468 | 70,008 | 62,465 | 59,867 |
| Cost of Goods | 8,799 | 8,177 | 7,115 | 8,574 | 5,552 |
| Gross Profit | 68,315 | 65,291 | 62,893 | 53,891 | 54,315 |
| Operating Expenses | 35,076 | 35,546 | 42,696 | 30,511 | 40,633 |
| Operating Income | 33,239 | 29,745 | 20,197 | 23,380 | 13,682 |
| Interest Expense | 1,047 | 1,099 | 1,117 | 1,067 | 1,146 |
| Other Income | 3,498 | 3,316 | 3,076 | 2,036 | -11,363 |
| Pre-tax Income | 35,690 | 31,962 | 22,156 | 24,349 | 1,173 |
| Income Tax | -175,104 | 411 | 643 | 1,005 | -256 |
| Net Income Continuous | 210,794 | 31,551 | 21,513 | 23,344 | 1,429 |
| Net Income | $210,794 | $31,551 | $21,513 | $23,344 | $1,429 |
| EBITDA(a) | $41,601 | $37,926 | $28,137 | $30,272 | $7,181 |